Journal Information

Statistics

Special Article

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab

Luis Figuero-Péreza,b,

,◊, Alejandro Olivares-Hernándeza,b,◊, Roberto A. Escala-Cornejob,c, Eduardo Terán-Bragea,b, Álvaro López-Gutiérreza,b, Juan J. Cruz-Hernándeza,b

a Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, Spain

b Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

c Servicio de Oncología Médica, Complejo Universitario de Ávila, Ávila, Spain

Read

619

Times
was read the article

Total PDF

545

Total HTML

Total EPUB

Share statistics

Article information

ISSN: 21735743
Original language: English

The statistics are updated each day

Year/Month	Html	Pdf	Epub	Total

2021 January	212	17	0	229
2020 December	148	21	0	169
2020 November	95	22	0	117
2020 October	90	14	0	104

Subscribe to our newsletter